Company / Return on Equity (ROE)
PLUS THERAPEUTICS, INC. Return on Equity (ROE) History
FY2012-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-206.5%
FY2018
5-year range
-206.5% / -153.6%
FY2014-FY2018
Trend
-2.9%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PLUS THERAPEUTICS, INC. reports negative total equity of -206.5% in FY2018. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-206.5% in FY2018 with a 5-year CAGR of +119.8%.
Declined from -153.6% to -206.5% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- +119.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2018, return on equity (roe) decreased 2.9% year-over-year.
- Peak return on equity (roe) was recorded in FY2012.
- Lowest return on equity (roe) in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2018 | -206.5% | -2.9% |
| FY2017 | -200.7% | -30.7% |
| FY2016 | -153.6% | - |
| FY2015 | - | - |
| FY2014 | -500.1% | -53.3% |
| FY2013 | -326.3% | -171.4% |
| FY2012 | -120.2% | - |
| FY2011 | - | - |
As of FY2018 · SEC 10-K · Updated Jun 28, 2026